Primary hyperaldosteronism
ICD-10 E26.0 is a billable code used to indicate a diagnosis of primary hyperaldosteronism.
Primary hyperaldosteronism, also known as Conn's syndrome, is an endocrine disorder characterized by excessive production of the hormone aldosterone from the adrenal glands. This condition leads to an imbalance of electrolytes, particularly sodium and potassium, resulting in hypertension and potential cardiovascular complications. The adrenal glands, located atop each kidney, are responsible for producing various hormones, including aldosterone, which regulates sodium and potassium levels in the body. In primary hyperaldosteronism, the overproduction of aldosterone causes the kidneys to retain sodium and excrete potassium, leading to increased blood volume and elevated blood pressure. Patients may present with symptoms such as headaches, muscle weakness, fatigue, and palpitations. Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and conducting imaging studies to identify adrenal adenomas or hyperplasia. Treatment options include mineralocorticoid receptor antagonists, surgical removal of adrenal tumors, or lifestyle modifications to manage hypertension. Understanding the pathophysiology and clinical implications of primary hyperaldosteronism is crucial for effective management and coding.
Detailed documentation of hormone levels, imaging studies, and treatment plans.
Patients presenting with resistant hypertension or unexplained hypokalemia.
Ensure all relevant lab results and imaging studies are included in the documentation.
Documentation of cardiovascular assessments and management plans related to hypertension.
Patients with hypertension and arrhythmias potentially linked to electrolyte imbalances.
Document any cardiovascular complications that may arise from hyperaldosteronism.
Used to confirm diagnosis of primary hyperaldosteronism.
Document the reason for the test and results.
Endocrinologists should ensure comprehensive lab results are included.
Common symptoms include hypertension, muscle weakness, fatigue, and palpitations due to electrolyte imbalances.
Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and imaging studies to identify adrenal abnormalities.
